Eyenovia and Taiwan-based development partner Formosa Pharmaceuticals on Monday announced that the FDA has approved their clobetasol propionate 0.05% eye drops for the treatment of post-operative inflammation and pain after eye surgery.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,